PREVACID is contraindicated in the Patients with known severe hypersensitivity to any component of the formulation. Hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, and urticarial.
Tablet: Proton Pump Inhibitors (PPIs), including PREVACID FDT are contraindicated with rilpivirine-containing products (see Interactions).
IV: Patients who are receiving atazanavir sulfate or ripilvirine hydrochloride. (see Interactions).